A team has identified a previously unknown phase of the immune response. The results challenge long-standing assumptions about the process called 'T-cell priming'. These new insights have significant ...
NUTLEY, N.J., June 27, 2024 /PRNewswire/ -- Eisai today announced results from a post-hoc analysis from the Phase 3 REFLECT trial, which looked at efficacy outcomes characterized by depth of response ...
Effect of fusion of radiomic, pathomic, and clinical biomarkers on multi-scale tumor biology and OS stratification in HNSCC receiving standard of care (SOC). Phase 2 trial of ozuriftamab vedotin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback